Literature DB >> 29703645

Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.

O Grimm1, R Kraehenmann2, K H Preller2, E Seifritz2, F X Vollenweider2.   

Abstract

Recent studies suggest that the antidepressant effects of the psychedelic 5-HT2A receptor agonist psilocybin are mediated through its modulatory properties on prefrontal and limbic brain regions including the amygdala. To further investigate the effects of psilocybin on emotion processing networks, we studied for the first-time psilocybin's acute effects on amygdala seed-to-voxel connectivity in an event-related face discrimination task in 18 healthy volunteers who received psilocybin and placebo in a double-blind balanced cross-over design. The amygdala has been implicated as a salience detector especially involved in the immediate response to emotional face content. We used beta-series amygdala seed-to-voxel connectivity during an emotional face discrimination task to elucidate the connectivity pattern of the amygdala over the entire brain. When we compared psilocybin to placebo, an increase in reaction time for all three categories of affective stimuli was found. Psilocybin decreased the connectivity between amygdala and the striatum during angry face discrimination. During happy face discrimination, the connectivity between the amygdala and the frontal pole was decreased. No effect was seen during discrimination of fearful faces. Thus, we show psilocybin's effect as a modulator of major connectivity hubs of the amygdala. Psilocybin decreases the connectivity between important nodes linked to emotion processing like the frontal pole or the striatum. Future studies are needed to clarify whether connectivity changes predict therapeutic effects in psychiatric patients.
Copyright © 2018 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Amygdala; Face recognition; Functional connectivity; Psilocybin

Mesh:

Substances:

Year:  2018        PMID: 29703645     DOI: 10.1016/j.euroneuro.2018.03.016

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  12 in total

1.  Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity.

Authors:  Anya K Bershad; Katrin H Preller; Royce Lee; Sarah Keedy; Jamie Wren-Jarvis; Michael P Bremmer; Harriet de Wit
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-12-20

2.  Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.

Authors:  Conor H Murray; Ilaria Tare; Claire M Perry; Michael Malina; Royce Lee; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2021-10-06       Impact factor: 4.530

Review 3.  Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.

Authors:  Juliana M Rocha; Flávia L Osório; José Alexandre S Crippa; José Carlos Bouso; Giordano N Rossi; Jaime E C Hallak; Rafael G Dos Santos
Journal:  Ther Adv Psychopharmacol       Date:  2019-04-26

Review 4.  Modulation of Social Cognition via Hallucinogens and "Entactogens".

Authors:  Katrin H Preller; Franz X Vollenweider
Journal:  Front Psychiatry       Date:  2019-12-03       Impact factor: 4.157

Review 5.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

Review 6.  Prefrontal contributions to the stability and variability of thought and conscious experience.

Authors:  Andre Zamani; Robin Carhart-Harris; Kalina Christoff
Journal:  Neuropsychopharmacology       Date:  2021-09-20       Impact factor: 7.853

Review 7.  Psychedelic Cognition-The Unreached Frontier of Psychedelic Science.

Authors:  Maria Bălăeţ
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

Review 8.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

9.  Emotions and brain function are altered up to one month after a single high dose of psilocybin.

Authors:  Frederick S Barrett; Manoj K Doss; Nathan D Sepeda; James J Pekar; Roland R Griffiths
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379

Review 10.  Natural Psychoplastogens As Antidepressant Agents.

Authors:  Jakub Benko; Stanislava Vranková
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.